CYTOKINETICS INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cytokinetics Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Cytokinetics Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $573M, a 29% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $573M +$129M +29% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $444M +$117M +35.6% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $327M +$52.6M +19.1% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $275M +$28.9M +11.8% Dec 31, 2020 10-K 2022-02-25
Q4 2019 $246M +$24.8M +11.2% Dec 31, 2019 10-K 2021-02-26
Q4 2018 $221M +$16.2M +7.91% Dec 31, 2018 10-K 2020-03-04
Q4 2017 $205M -$11.7M -5.42% Dec 31, 2017 10-K 2019-03-07
Q4 2016 $217M -$2.15M -0.98% Dec 31, 2016 10-K 2018-03-05
Q4 2015 $219M +$13.9M +6.79% Dec 31, 2015 10-K 2018-03-05
Q4 2014 $205M +$1.04M +0.51% Dec 31, 2014 10-K 2017-03-06
Q4 2013 $204M +$13.7M +7.19% Dec 31, 2013 10-K 2016-03-03
Q4 2012 $190M +$21.1M +12.5% Dec 31, 2012 10-K 2015-03-06
Q4 2011 $169M +$18.5M +12.3% Dec 31, 2011 10-K 2014-03-07
Q4 2010 $151M Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.